Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperaldosteronism | 70 | 2024 | 240 | 16.890 |
Why?
|
Adrenalectomy | 42 | 2024 | 341 | 5.780 |
Why?
|
Aldosterone | 41 | 2024 | 877 | 4.580 |
Why?
|
Adrenocortical Adenoma | 12 | 2023 | 48 | 3.860 |
Why?
|
Adrenal Cortex Neoplasms | 7 | 2021 | 162 | 2.070 |
Why?
|
Hypertension | 29 | 2023 | 8480 | 1.990 |
Why?
|
Adrenal Glands | 15 | 2023 | 546 | 1.880 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1972 | 1.380 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 8 | 2023 | 64 | 1.120 |
Why?
|
Adrenal Gland Neoplasms | 6 | 2023 | 740 | 1.110 |
Why?
|
Adenoma | 9 | 2023 | 2174 | 1.040 |
Why?
|
Taiwan | 21 | 2023 | 496 | 1.040 |
Why?
|
Hydrocortisone | 10 | 2023 | 1826 | 1.000 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 93 | 0.890 |
Why?
|
Interleukin-18 | 1 | 2022 | 249 | 0.780 |
Why?
|
Cushing Syndrome | 1 | 2020 | 249 | 0.660 |
Why?
|
Otoscopy | 1 | 2018 | 36 | 0.630 |
Why?
|
Renin | 9 | 2023 | 642 | 0.620 |
Why?
|
Diastole | 3 | 2020 | 791 | 0.610 |
Why?
|
Renal Dialysis | 7 | 2020 | 1786 | 0.600 |
Why?
|
Embolization, Therapeutic | 3 | 2021 | 1392 | 0.560 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2208 | 0.560 |
Why?
|
Ear Diseases | 1 | 2018 | 170 | 0.550 |
Why?
|
Creatinine | 6 | 2023 | 1919 | 0.520 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2014 | 72 | 0.500 |
Why?
|
Salvage Therapy | 1 | 2021 | 1275 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2020 | 2073 | 0.460 |
Why?
|
Hemofiltration | 1 | 2013 | 57 | 0.440 |
Why?
|
Liver Transplantation | 1 | 2023 | 2119 | 0.420 |
Why?
|
Uremia | 1 | 2013 | 201 | 0.420 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2016 | 964 | 0.400 |
Why?
|
Intracranial Pressure | 1 | 2013 | 326 | 0.380 |
Why?
|
Otolaryngology | 1 | 2018 | 645 | 0.380 |
Why?
|
Liver Neoplasms | 3 | 2021 | 4253 | 0.370 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2170 | 0.370 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2219 | 0.360 |
Why?
|
Humans | 100 | 2024 | 744343 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 1008 | 0.330 |
Why?
|
Renal Replacement Therapy | 3 | 2021 | 257 | 0.320 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15165 | 0.310 |
Why?
|
Middle Aged | 48 | 2023 | 213383 | 0.300 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2538 | 0.280 |
Why?
|
Mitral Valve | 1 | 2014 | 1491 | 0.270 |
Why?
|
Adult | 39 | 2023 | 214055 | 0.270 |
Why?
|
Ventricular Remodeling | 4 | 2023 | 1224 | 0.260 |
Why?
|
Steroid 11-beta-Hydroxylase | 2 | 2022 | 20 | 0.260 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3670 | 0.260 |
Why?
|
Treatment Outcome | 23 | 2023 | 63114 | 0.260 |
Why?
|
Male | 51 | 2023 | 350118 | 0.260 |
Why?
|
Female | 49 | 2023 | 380194 | 0.240 |
Why?
|
Retrospective Studies | 30 | 2023 | 77449 | 0.240 |
Why?
|
Captopril | 2 | 2023 | 272 | 0.220 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 859 | 0.220 |
Why?
|
Hemodynamics | 1 | 2013 | 4199 | 0.220 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 68 | 0.220 |
Why?
|
Adosterol | 2 | 2023 | 6 | 0.210 |
Why?
|
Calcium Channels, T-Type | 1 | 2022 | 34 | 0.210 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.210 |
Why?
|
Aged | 32 | 2023 | 163280 | 0.200 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2647 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3327 | 0.200 |
Why?
|
Prospective Studies | 13 | 2024 | 53288 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 11725 | 0.200 |
Why?
|
Renal Insufficiency | 2 | 2022 | 804 | 0.190 |
Why?
|
Antihypertensive Agents | 5 | 2023 | 2046 | 0.190 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4042 | 0.190 |
Why?
|
Echocardiography | 6 | 2023 | 5102 | 0.190 |
Why?
|
Spironolactone | 2 | 2021 | 382 | 0.190 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2019 | 13 | 0.180 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 104 | 0.180 |
Why?
|
Blood Specimen Collection | 3 | 2021 | 246 | 0.180 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2645 | 0.180 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 247 | 0.180 |
Why?
|
Hearing Aids | 1 | 2020 | 55 | 0.180 |
Why?
|
Cohort Studies | 7 | 2024 | 40561 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1240 | 0.170 |
Why?
|
Pericardium | 1 | 2023 | 667 | 0.170 |
Why?
|
Brachial Artery | 1 | 2020 | 369 | 0.170 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 361 | 0.160 |
Why?
|
Specimen Handling | 2 | 2020 | 694 | 0.160 |
Why?
|
Aftercare | 1 | 2024 | 866 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2020 | 2214 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1133 | 0.150 |
Why?
|
Patient Positioning | 1 | 2019 | 324 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1791 | 0.140 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 434 | 0.140 |
Why?
|
Risk Factors | 13 | 2024 | 72290 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 817 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2012 | 969 | 0.140 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.130 |
Why?
|
Consensus | 3 | 2021 | 2959 | 0.130 |
Why?
|
Angiography | 1 | 2020 | 1639 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2018 | 620 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2021 | 658 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 526 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 293 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29063 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1239 | 0.120 |
Why?
|
Heart Failure | 3 | 2023 | 10900 | 0.120 |
Why?
|
Mutation | 7 | 2023 | 29786 | 0.110 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 2031 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 765 | 0.110 |
Why?
|
Stroke Volume | 2 | 2016 | 5007 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5751 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.100 |
Why?
|
Automation | 1 | 2014 | 584 | 0.100 |
Why?
|
Observer Variation | 2 | 2016 | 2593 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 984 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5034 | 0.100 |
Why?
|
Sepsis | 2 | 2018 | 2593 | 0.100 |
Why?
|
Ankle Brachial Index | 2 | 2022 | 154 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1671 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1210 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1585 | 0.090 |
Why?
|
Kidney Function Tests | 3 | 2022 | 684 | 0.090 |
Why?
|
Alleles | 1 | 2021 | 6933 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6538 | 0.090 |
Why?
|
Disease Management | 2 | 2021 | 2459 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15076 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 9959 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2021 | 164 | 0.080 |
Why?
|
Time Factors | 7 | 2021 | 40075 | 0.080 |
Why?
|
Incidence | 7 | 2020 | 20947 | 0.080 |
Why?
|
Comorbidity | 6 | 2020 | 10388 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3200 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2133 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57776 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2019 | 2886 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2029 | 0.080 |
Why?
|
Intensive Care Units | 3 | 2016 | 3679 | 0.080 |
Why?
|
Liver | 1 | 2023 | 7474 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2022 | 13033 | 0.070 |
Why?
|
Fibroblasts | 1 | 2018 | 4161 | 0.070 |
Why?
|
Risk Assessment | 8 | 2021 | 23338 | 0.070 |
Why?
|
Critical Illness | 3 | 2021 | 2670 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3864 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19905 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1813 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20129 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39050 | 0.070 |
Why?
|
Blood Glucose | 1 | 2020 | 6256 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2010 | 465 | 0.070 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1320 | 0.070 |
Why?
|
Hospital Mortality | 6 | 2018 | 5317 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3064 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3743 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12720 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4776 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.060 |
Why?
|
Databases, Factual | 4 | 2020 | 7729 | 0.060 |
Why?
|
Biological Assay | 2 | 2018 | 652 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3047 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1118 | 0.060 |
Why?
|
Fibrosis | 2 | 2022 | 2029 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 687 | 0.060 |
Why?
|
Veins | 2 | 2018 | 770 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 962 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3537 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3752 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2151 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2023 | 648 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 67 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 180 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2149 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2019 | 21746 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1400 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 164 | 0.050 |
Why?
|
Cosyntropin | 1 | 2020 | 33 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12745 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2021 | 5078 | 0.050 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.050 |
Why?
|
Cystatin C | 1 | 2021 | 250 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 690 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
Catheterization | 2 | 2017 | 1470 | 0.040 |
Why?
|
Diuretics | 1 | 2022 | 592 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25043 | 0.040 |
Why?
|
Caspase 3 | 1 | 2021 | 758 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 610 | 0.040 |
Why?
|
Critical Care | 1 | 2011 | 2647 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.040 |
Why?
|
Thrombectomy | 1 | 2023 | 680 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 930 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 739 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3527 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10252 | 0.040 |
Why?
|
Germany | 1 | 2019 | 862 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12354 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 924 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15540 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21827 | 0.040 |
Why?
|
Phlebotomy | 1 | 2018 | 141 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9981 | 0.040 |
Why?
|
Kidney | 2 | 2022 | 7186 | 0.040 |
Why?
|
Microspheres | 1 | 2019 | 777 | 0.030 |
Why?
|
Phlebography | 1 | 2017 | 333 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 889 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 634 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3129 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 935 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 383 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 854 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1654 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 2025 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2274 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Fasting | 1 | 2020 | 1593 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
Blood Pressure | 2 | 2023 | 8554 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2161 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1003 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2386 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1018 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
Polysomnography | 1 | 2019 | 1776 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4186 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1637 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2902 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2020 | 1928 | 0.030 |
Why?
|
APACHE | 1 | 2012 | 277 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3271 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12959 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6314 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1807 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15295 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2689 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13815 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2616 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13284 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1475 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3719 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1177 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3584 | 0.020 |
Why?
|
Observation | 1 | 2009 | 312 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11366 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5255 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4215 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7785 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6580 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13989 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168757 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81183 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5300 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6442 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19229 | 0.010 |
Why?
|
Survivors | 1 | 2012 | 2291 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9583 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85781 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13408 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|